Full Text View
Tabular View
No Study Results Posted
Related Studies
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
This study has been terminated.
Study NCT00941486   Information provided by Foresight Biotherapeutics

First Received on July 15, 2009.   Last Updated on September 5, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Acute Adenoviral Conjunctivitis
Additional conditions recognized in this trial
Conjunctivitis
Conjunctivitis, Inclusion
More general conditions related to this trial
Bacterial Infections
Chlamydia Infections
Chlamydiaceae Infections
Conjunctival Diseases
Conjunctivitis, Bacterial
Eye Diseases
Eye Infections
Eye Infections, Bacterial
Gram-Negative Bacterial Infections
Infection
Interventions listed in this trial
Placebo
Additional drug interventions recognized in this trial
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antiemetics
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Autonomic Agents
Central Nervous System Agents
Enzyme Inhibitors
Gastrointestinal Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Foresight Biotherapeutics


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services